Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.160
+0.070 (6.42%)
Nov 20, 2024, 4:00 PM EST - Market closed
Dermata Therapeutics Employees
Dermata Therapeutics had 8 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,408,812
Market Cap
1.75M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 8 | 0 | - |
| Dec 31, 2021 | 8 | 1 | 14.29% |
| Dec 31, 2020 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| cbdMD | 52 |
| Helius Medical Technologies | 22 |
| TFF Pharmaceuticals | 19 |
| Altamira Therapeutics | 10 |
| Tivic Health Systems | 9 |
| SCWorx | 7 |
| Allarity Therapeutics | 6 |
| GlucoTrack | 6 |
DRMA News
- 7 days ago - Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - Accesswire
- 9 days ago - Dermata Therapeutics to Present at the Life Sciences Investor Forum on Thursday, November 14, 2024 - GlobeNewsWire
- 6 weeks ago - Dermata Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024 - Accesswire
- 2 months ago - Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Accesswire
- 2 months ago - Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Accesswire
- 2 months ago - Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024 - Accesswire
- 3 months ago - Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results - Accesswire
- 4 months ago - Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne - Accesswire